Qinghe Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Qinghe Xu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bing Wang
Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230001 Anhui, China
1 shared publication - Bingfeng Zhou
Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230001 Anhui, China
1 shared publication - Birong Zhou
Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China
1 shared publication - Jianfa Zheng
Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230001 Anhui, China
1 shared publication - Minmin Fu
Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230001 Anhui, China
1 shared publication - Shaodong Xu
Department of Cardiology The Third Affiliated Hospital of Anhui Medical University Hefei Anhui Province China
1 shared publication
Latest Publications
- RetractedOpen Access
- 22 July 2022
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome
Background. The level of HbA1c can reflect the average level of blood glucose over 3 months, which is the gold standard indicator for monitoring blood glucose. The relationship between the level of HbA1c and the extent of coronary atherosclerosis lesions or the prognosis in diabetes with acute coronary syndrome (ACS) remains poorly understood. Aims. To explore whether the level of HbA1c can evaluate the extent of coronary atherosclerosis lesions or the prognosis in diabetes with acute coronary syndrome (ACS) using the SYNTAX score, the Global Registry of Acute Coronary Events (GRACE) score, left ventricular function (LVEF), left ventricular end-diastolic volume (LVEDV), and major adverse cardiac events (MACEs) in the hospital and 12 months after discharge. Methods. This study was a prospective, randomized, open-label, and parallel group study. Patients with diabetes with ACS were recruited into this study indiscriminately, and all the participants were divided into two groups according to the level of HbA1c: and . The followings were used as the evaluation indicators: SYNTAX score, GRACE score, LVEF, LVEDV, and MACEs in hospital and 12 months after discharge. Results. A total of 233 patients with diabetes and ACS were enrolled and assigned to two groups according to their level of HbA1c: the ( ) and the ( ). The results showed that the proportion of STEMI was higher in the HbA1c ≤7% group ( ), while the proportion of NSTEMI has not significantly higher in the HbA1c >7% group ( ). Regression analysis indicated that HbA1c level was significantly positively correlated with GRACE score (
- 22 July 2022
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
RetractedOpen AccessThe Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome
Background. The level of HbA1c can reflect the average level of blood glucose over 3 months, which is the gold standard indicator for monitoring blood glucose. The relationship between the level of HbA1c and the extent of coronary atherosclerosis lesions or the prognosis in diabetes with acute coronary syndrome (ACS) remains poorly understood. Aims. To explore whether the level of HbA1c can evaluate the extent of coronary atherosclerosis lesions or the prognosis in diabetes with acute coronary syndrome (ACS) using the SYNTAX score, the Global Registry of Acute Coronary Events (GRACE) score, left ventricular function (LVEF), left ventricular end-diastolic volume (LVEDV), and major adverse cardiac events (MACEs) in the hospital and 12 months after discharge. Methods. This study was a prospective, randomized, open-label, and parallel group study. Patients with diabetes with ACS were recruited into this study indiscriminately, and all the participants were divided into two groups according to the level of HbA1c: and . The followings were used as the evaluation indicators: SYNTAX score, GRACE score, LVEF, LVEDV, and MACEs in hospital and 12 months after discharge. Results. A total of 233 patients with diabetes and ACS were enrolled and assigned to two groups according to their level of HbA1c: the ( ) and the ( ). The results showed that the proportion of STEMI was higher in the HbA1c ≤7% group ( ), while the proportion of NSTEMI has not significantly higher in the HbA1c >7% group ( ). Regression analysis indicated that HbA1c level was significantly positively correlated with GRACE score (